Keele Research Repository

Article

Strange, RC, König, CS, Ahmed, A, Hackett, G, Haider, A, Haider, KS, Desnerck, P, Saad, F, Lorde, N, Maarouf, A and Ramachandran, S (2021) Testosterone Therapy: Increase in Hematocrit is Associated with Decreased Mortality. Androgens: Clinical Research and Therapeutics, 2 (1). 150 - 159.

Lorde, N, Maarouf, A, Strange, RC, König, CS, Hackett, G, Haider, A, Haider, KS, Desnerck, P, Saad, F and Ramachandran, S (2021) Testosterone Therapy in Adult-Onset Testosterone Deficiency: Hematocrit and Hemoglobin Changes. Androgens: Clinical Research and Therapeutics, 2 (1). 141 - 149.

Ramachandran, S, Konig, C, Hackett, G, Livingston, M and Strange, RC (2018) Managing Clinical Heterogeneity: An Argument for Benefit-Based Action Limits. Journal of Engineering in Medical Diagnostics and Therapy, 1 (3).

Hackett, G, Cole, N, Saghir, A, Jones, P, Strange, RC and Ramachandran, S (2017) Testosterone replacement therapy: improved sexual desire and erectile function in men with type 2 diabetes following a 30-week randomized placebo-controlled study. Andrology, 5 (5). 905 - 913.

Hackett, G, Ramachandran, S, Strange, R and Jones, PW (2016) 004 Long Term Therapy With Testosterone Undecanoate in Type 2 Diabetes was Associated With Reduced All-Cause Mortality but no Significant Improvement in Conventional Risk Factors for CVD. The Journal of Sexual Medicine, 14 (1). S2 - S3.

Hackett, G, Cole, N, Saghir, A, Jones, P, Strange, RC and Ramachandran, S (2016) Testosterone Undecanoate improves Sexual Function in Men with Type 2 diabetes and Severe Hypogonadism: Results from a 30 week randomized placebo controlled study. BJU Int, 118 (5). pp. 804-813.